胰十二指肠切除术后早期肠内营养与口服营养比较:NUTRIWHI随机临床试验
这项在瑞士和法国3个中心进行的平行、开放标签、优效性随机临床试验,纳入营养风险筛查评分≥3的胰十二指肠切除术后患者,比较早期肠内营养(EEN)与口服营养(ON)对术后并发症的影响。
要点
- 营养风险筛查评分≥3的胰十二指肠切除患者,术后EEN可降低90天综合并发症指数。
- EEN组与ON组在总体并发症率、胰瘘、胃排空延迟等特定并发症上无显著差异。
- EEN组有14例因鼻空肠管非计划拔除而重置管,需注意导管相关不良事件。
研究设计与样本
- 平行、开放标签、优效性随机临床试验,在瑞士和法国3个三级中心进行。
- 纳入营养风险筛查评分≥3的患者,随机1:1分为早期肠内营养组和口服营养组。
- 共144例患者入组,142例随机化,24例退出(17%),最终118例纳入分析(每组59例)。
主要发现
- 两组在胃排空延迟、胰瘘、术后出血和手术部位感染等特定并发症上均无差异。
- EEN组有14例患者因鼻空肠管非计划拔除而重置管(不良事件)。
关键数值与推荐
- 营养风险筛查评分≥3定义为营养风险增加。
- EEN组术后立即经术中放置的鼻空肠管给予肠内营养,并允许按与ON组相同的方案口服进食。
- ON组住院期间不允许肠内营养;两组肠外营养需求均标准化。
临床怎么用
- 对于营养风险筛查评分≥3的胰十二指肠切除患者,可考虑术后早期经鼻空肠管肠内营养以降低综合并发症负担。
- 实施EEN时需关注鼻空肠管非计划拔除风险,本研究中EEN组有14例因此重置管。
局限性
- 开放标签设计可能引入偏倚。
- 随机化后24例(17%)退出,最终仅118例纳入分析。
- 样本量有限,特定并发症的比较可能效力不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The optimal type of nutritional support after pancreatoduodenectomy remains controversial. OBJECTIVE: To compare postoperative early enteral nutrition (EEN) with oral nutrition (ON) in patients nutritionally at risk in terms of postoperative morbidity. DESIGN, SETTING, AND PARTICIPANTS: This study was a parallel, open-label, superiority randomized clinical trial that took place at 3 tertiary centers in Switzerland and France. Patients at increased nutritional risk (nutritional risk screening score ≥3) were randomized 1:1 into the EEN or ON groups. Patients in the EEN group received enteral nutrition immediately after surgery via a nasojejunal tube placed intraoperatively and were allowed to have oral food based on the same protocol as the other group. Patients in the ON group were not allowed to have enteral nutrition during hospitalization. In both groups, parenteral nutrition need was standardized. These data were analyzed from February 2025 to April 2025. INTERVENTION: EEN via nasojejunal tube vs ON. MAIN OUTCOMES AND MEASURES: Primary outcome was complications at 90 days postoperatively, defined by the mean comprehensive complication index. Secondary end points were morbidity rates (overall, minor, and major complications), mortality, delayed gastric emptying, pancreatic fistula, postoperative hemorrhage, surgical site infections, infectious complications, pulmonary complications, length of stay, and 90-day readmission. RESULTS: Patients were enrolled from December 15, 2021, through October 8, 2024. A total of 144 patients were included and 142 patients were randomized. After randomization, 24 patients dropped out (17%), leaving 118 patients for analysis (59 in the EEN group and 59 in the ON group). Patients in the EEN group had a lower mean 90-day comprehensive complication index compared with ON patients (mean [SD], 25.5 [21.1] vs 35.8 [25.2]; mean difference 10.3; 95% CI 1.8-18.8; P = .02). At 90 days, overall morbidity rates were 45 of 59 and 51 of 59 in the EEN and ON groups (risk ratio [RR], 1.13; 95% CI, 0.9-1.9; P = .18). No difference was found between both groups regarding specific complications (delayed gastric emptying, pancreatic fistula, postoperative hemorrhage, and surgical site infection). In the EEN group, nasojejunal tube was replaced in 14 patients due to involuntary removal (adverse event). CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, in patients with a nutritional risk screening score of 3 or more, EEN after pancreatoduodenectomy permitted to decrease the burden and incidence of postoperative complications compared with ON. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05042882.
引用
- Joliat GR, Martin D, Labgaa I, et al. Early Enteral vs Oral Postoperative Nutrition After Pancreatoduodenectomy: The NUTRIWHI Randomized Clinical Trial. JAMA Surg. 2026. PMID: 42018334. doi:10.1001/jamasurg.2026.1048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。